Francesco Buccisano

Associate Professor

UNIVERSITY TOR VERGATA

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

Roland B. Walter

University of Washington

UNITED STATES

View details

Maria Teresa Petrucci

ITALY

View details

MARIA TERESA BOCHICCHIO

IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori

ITALY

View details

GIORGIA SIMONETTI

IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori

ITALY

View details

Giulia Ciotti

Istituto Oncologico Veneto

ITALY

View details

Farhad Ravandi

Professor of Medicine, Chief Section of AML

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

maria ilaria del principe

UNIVERSITY TOR VERGATA

ITALY

View details

Maria Teresa VOSO

Professore Ordinario di Ematologia

Università degli Studi di Roma Tor Vergata Facoltà di Medicina e Chirurgia

ITALY

View details

Paolo de Fabritiis

University of Rome Tor Vergata

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Francesco Buccisano

Research Interests

Explore related searches

Contact this professor

Articles (11)

Relapse Prevention in Acute Myeloid Leukemia: The Role of Immunotherapy with Histamine Dihydrochloride and Low-Dose Interleukin-2

Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower‐intensity therapy: Roadmap from an ELN‐DAVID expert panel

Consensus for Flow Cytometry Clinical Report on Multiple Myeloma: A Multicenter Harmonization Process Merging Laboratory Experience and Clinical Needs

Measurable Residual Disease (MRD) as a Surrogate Efficacy-Response Biomarker in AML

Measurable Residual Disease and Clonal Evolution in Acute Myeloid Leukemia from Diagnosis to Post-Transplant Follow-Up: The Role of Next-Generation Sequencing

AML: making residual disease more measurable

Time for Dynamic Assessment of Fitness in Acute Myeloid Leukemia

Predictors of Early Thrombotic Events in Adult Patients with Acute Myeloid Leukemia: A Real-World Experience

Validation of the T-Lymphocyte Subset Index (TLSI) as a Score to Predict Mortality in Unvaccinated Hospitalized COVID-19 Patients

Myelodysplastic Syndromes with Isolated 20q Deletion: A New Clinical–Biological Entity?

ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol

Collaborators (9)

Roland B. Walter

Maria Teresa Petrucci

MARIA TERESA BOCHICCHIO

GIORGIA SIMONETTI

Giulia Ciotti

Farhad Ravandi

maria ilaria del principe

Maria Teresa VOSO

Paolo de Fabritiis

Make your next move.